Skip to main content
رجوع
SHWGF logo

Shandong Weigao Group Medical Polymer Company Limited

جودة البيانات: 100%
ذروة شراء
SHWGF
OTC Healthcare Medical - Instruments & Supplies
KWD 0.73
KWD 0.00 (0.00%)
القيمة السوقية: 3.26B
مُدرج أيضًا باسم SHWGY OTC
نطاق اليوم
KWD 0.73 KWD 0.73
نطاق 52 أسبوعًا
KWD 0.66 KWD 0.76
حجم التداول
4,200
متوسط 50 يوم / 200 يوم
KWD 0.69 / KWD 0.73
الإغلاق السابق
KWD 0.73

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 1.6 0.3
P/B 0.1 2.9
ROE % 9.0 3.7
Net Margin % 15.8 3.8
Rev Growth 5Y % 3.0 10.0
D/E 0.2 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2027 KWD 0.534
KWD 0.509 – KWD 0.561
16 B 1
FY2026 KWD 0.489
KWD 0.465 – KWD 0.513
15 B 1

النقاط الرئيسية

Revenue grew 3.01% annually over 5 years — modest growth
Net margin of 15.79% shows strong profitability
Debt/Equity of 0.18 — conservative balance sheet
Generating 2.14B in free cash flow
P/E of 1.58 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.09%

النمو

Revenue Growth (5Y)
3.01%
Revenue (1Y)-1.08%
Earnings (1Y)3.24%
FCF Growth (3Y)39.67%

الجودة

Return on Equity
8.95%
ROIC6.40%
Net Margin15.79%
Op. Margin18.23%

الأمان

Debt / Equity
0.18
Current Ratio3.20
Interest Coverage9.56

التقييم

P/E Ratio
1.58
P/B Ratio0.14
EV/EBITDA-0.14
Dividend Yield0.04%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -1.08% Revenue Growth (3Y) -1.97%
Earnings Growth (1Y) 3.24% Earnings Growth (3Y) -13.53%
Revenue Growth (5Y) 3.01% Earnings Growth (5Y) -0.24%
Profitability
Revenue (TTM) 13.09B Net Income (TTM) 2.07B
ROE 8.95% ROA 5.95%
Gross Margin 50.28% Operating Margin 18.23%
Net Margin 15.79% Free Cash Flow (TTM) 2.14B
ROIC 6.40% FCF Growth (3Y) 39.67%
Safety
Debt / Equity 0.18 Current Ratio 3.20
Interest Coverage 9.56 Dividend Yield 0.04%
Valuation
P/E Ratio 1.58 P/B Ratio 0.14
P/S Ratio 0.25 PEG Ratio 2.36
EV/EBITDA -0.14 Dividend Yield 0.04%
Market Cap 3.26B Enterprise Value -326.77M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 13.09B 13.23B 13.62B 13.15B 11.62B
Net Income 2.07B 2.00B 2.76B 2.28B 2.09B
EPS (Diluted) 0.45 0.44 0.61 0.50 0.46
Gross Profit 6.58B 6.64B 7.31B 7.35B 6.46B
Operating Income 2.39B 2.30B 2.92B 2.89B 2.28B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 34.76B 33.67B 33.20B 30.37B 27.34B
Total Liabilities 9.42B 9.68B 9.75B 9.46B 8.95B
Shareholders' Equity 23.75B 22.45B 21.67B 19.27B 17.55B
Total Debt 4.19B 4.17B 4.49B 4.14B 4.32B
Cash & Equivalents 7.78B 6.99B 6.86B 6.63B 5.51B
Current Assets 19.44B 18.63B 18.29B 16.26B 14.37B
Current Liabilities 6.08B 7.58B 5.93B 5.18B 4.50B

درجات الاستراتيجيات

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches

النشاط الأخير

دخل Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل Defensive Investing (Benjamin Graham)
Mar 24, 2026